English  |  正體中文  |  简体中文  |  總筆數 :2822924  
造訪人次 :  30038941    線上人數 :  1104
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 586-635 / 883 (共18頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-03T03:33:49Z Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response Hong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:49Z Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047)) Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:33:49Z Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:48Z A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma Yau T.C.C.; Lencioni R.; Sukeepaisarnjaroen W.; Chao Y.; Yen C.-J.; Lausoontornsiri W.; PEI-JER CHEN; Sanpajit T.; Camp A.; Cox D.S.; Gagnon R.C.; Liu Y.; Raffensperger K.E.; Kulkarni D.A.; Kallender H.; Ottesen L.H.; Poon R.T.P.; Bottaro D.P.
臺大學術典藏 2021-07-03T03:33:48Z De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline Lin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wang H.-Y.
臺大學術典藏 2021-07-03T03:33:48Z Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study Lu L.-C.; PEI-JER CHEN; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:33:47Z Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007)) Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:33:47Z Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Wu J.-F.; Chen H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:47Z Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Omata M.; Cheng A.-L.; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.
臺大學術典藏 2021-07-03T03:33:47Z Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S.
臺大學術典藏 2021-07-03T03:33:46Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:46Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:45Z The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Chen D.S.; PEI-JER CHEN; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Su T.H.; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H.
臺大學術典藏 2021-07-03T03:33:45Z Strategies to manage hepatitis C virus infection disease burden—Volume 4 Chen D.S.; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; PEI-JER CHEN; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D.
臺大學術典藏 2021-07-03T03:33:44Z Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma Lin Y.-Y.; Yu M.-W.; Lin S.-M.; Lee S.-D.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:44Z Historical epidemiology of hepatitis C virus in select countries—volume 4 Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen D.S.; PEI-JER CHEN; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Malu A.O.; Mateva L.; Mitova R.; Morovi? M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K.
臺大學術典藏 2021-07-03T03:33:43Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; PEI-JER CHEN; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:43Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:42Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H.; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:42Z Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein Wang Y.; Wu T.; Hu D.; Weng X.; Wang X.; PEI-JER CHEN; Luo X.; Wang H.; Ning Q.
臺大學術典藏 2021-07-03T03:33:42Z Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏 2021-07-03T03:33:42Z Exploring new therapies for a serological cure of chronic hepatitis B Horng J.-H.; Wu C.-R.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:41Z The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA Yang H.-C.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:41Z Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop Block T.M.; Alter H.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.F.; Guo J.-T.; Hoshida Y.; Kowdley K.V.; Li W.; Lok A.S.; McMahon B.; Mehta A.; Perrillo R.; Rice C.M.; Rinaudo J.; Schinazi R.F.; Shetty K.
臺大學術典藏 2021-07-03T03:33:41Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:40Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:40Z A research agenda for curing chronic hepatitis B virus infection Alter H.; Block T.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Chisari F.V.; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.; Guo H.; Guo J.-T.; Hoshida Y.; Hu J.; Kowdley K.V.; Li W.; Liang J.; Locarnini S.; Lok A.S.; Mason W.; McMahon B.; Mehta A.; Perrillo R.; Revill P.; Rice C.M.; Rinaudo J.; Schinazi R.; Seeger C.; Shetty K.; Tavis J.; Zoulim F.
臺大學術典藏 2021-07-03T03:33:40Z Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice Tsai C.-L.; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; Tzen K.-Y.; Cheng A.-L.; PEI-JER CHEN; Cheng J.C.-H.
臺大學術典藏 2021-07-03T03:33:39Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:39Z Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV Liu C.-J.; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:38Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:38Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:38Z Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Liu C.-J.; Yu M.-L.
臺大學術典藏 2021-07-03T03:33:37Z The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice Kang X.-Z.; Guo X.-R.; Chen B.-B.; Zhang T.-Y.; Yuan Q.; PEI-JER CHEN; Zhang J.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:37Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:37Z Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection Lin P.-H.; Wong W.-I.; Wang Y.-L.; Hsieh M.-P.; Lu C.-W.; Liang C.-Y.; Jui S.-H.; Wu F.-Y.; PEI-JER CHEN; Yang H.-C.
臺大學術典藏 2021-07-03T03:33:36Z Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-07-03T03:33:36Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:35Z Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients Hu H.-H.;Liu J.;Chang C.-L.;Jen C.-L.;Lee M.-H.;Lu S.-N.;Wang L.-Y.;Quan Y.;Xia N.-S.;Chen C.-J.;Pei-Jer Chen;Yang H.-I.; Hu H.-H.; Liu J.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Quan Y.; Xia N.-S.; Chen C.-J.; PEI-JER CHEN; Yang H.-I.
臺大學術典藏 2021-07-03T03:33:35Z Taiwan consensus statement on the management of chronic hepatitis B Chien R.-N.;Kao J.-H.;Peng C.-Y.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Hu T.-H.;Yang H.-I.;Lu S.-N.;Ni Y.-H.;Chuang W.-L.;Lee C.-M.;Wu J.-C.;Pei-Jer Chen;Liaw Y.-F.; Chien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN; Liaw Y.-F.
臺大學術典藏 2021-07-03T03:33:35Z Evaluation of SH-SAW Biosensor in Whole Blood Kano K.; Huang Y.-Q.; Kogai T.; Huang Y.-T.; Yatsuda H.; PEI-JER CHEN; Liu S.-H.
臺大學術典藏 2021-07-03T03:33:35Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:34Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J.;Tseng T.-C.;Yang W.-T.;Su T.-H.;Yang H.-C.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development Hu J.;Lin Y.-Y.;Pei-Jer Chen;Watashi K.;Wakita T.; Hu J.; Lin Y.-Y.; PEI-JER CHEN; Watashi K.; Wakita T.
臺大學術典藏 2021-07-03T03:33:33Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:33Z Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region Li C.-L.;Li C.-Y.;Lin Y.-Y.;Ho M.-C.;Chen D.-S.;Pei-Jer Chen;Yeh S.-H.; Li C.-L.; Li C.-Y.; Lin Y.-Y.; Ho M.-C.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:33Z Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase Wang Y.-H.;Chuang Y.-H.;Wu C.-F.;Jan M.-C.;Wu W.-J.;Lin C.-L.;Liu C.-J.;Yang Y.-C.;Pei-Jer Chen;Lin S.-M.;Tsai M.-H.;Huang Y.-W.;Yu M.-W.; Wang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; Liu C.-J.; Yang Y.-C.; PEI-JER CHEN; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:32Z Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice Wu L.-L.;Peng W.-H.;Wu H.-L.;Miaw S.-C.;Yeh S.-H.;Yang H.-C.;Liao P.-H.;Lin J.-S.;Chen Y.-R.;Hong Y.-T.;Wang H.-Y.;Pei-Jer Chen;Chen D.-S.; Wu L.-L.; Peng W.-H.; Wu H.-L.; Miaw S.-C.; Yeh S.-H.; Yang H.-C.; Liao P.-H.; Lin J.-S.; Chen Y.-R.; Hong Y.-T.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.

顯示項目 586-635 / 883 (共18頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目